I've given my IMU investment some basic critical analysis. My thinking is this:
IMU's products either work or they don't.
What does "work" mean? To me it simply means that they are clinically proven to be more effective and less toxic than the current SOC.
When will we know if they work or don't? When there is enough clinically verified data to demonstrate the efficacy and safety to a standard that satisfies the FDA and/or Big Pharma.
How long will this take? I have no idea, I'm not a scientist but my guess is anytime within the next 2 years.
If it works what's it worth? My guess worst case would be an absolute minimum of US 10 Billion or $2 per share. Best case is scary good.
Based on the above and based on all my reading and research and attending the Sydney presentation to hear from Yuman and Saul personally, I'm willing to put my money on the team succeeding to demonstrate that at least one of the products works.
Therefore, I'll get on with life and let the results come when they're ready.
All IMO, GLTAH!
- Forums
- ASX - By Stock
- Why IMU is a multi multi bagger
I've given my IMU investment some basic critical analysis. My...
-
- There are more pages in this discussion • 16,371 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $357.0M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.7¢ | $379.2K | 7.937M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 3773908 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 1293222 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 3552632 | 0.047 |
23 | 3044504 | 0.046 |
30 | 3803872 | 0.045 |
40 | 6966738 | 0.044 |
29 | 3216810 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 688107 | 6 |
0.049 | 3497564 | 11 |
0.050 | 6853048 | 24 |
0.051 | 2446049 | 14 |
0.052 | 1856295 | 13 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online